These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
478 related articles for article (PubMed ID: 30128047)
1. Molecular imaging of T cell co-regulator factor B7-H3 with Burvenich IJG; Parakh S; Lee FT; Guo N; Liu Z; Gan HK; Rigopoulos A; O'Keefe GJ; Gong SJ; Goh YW; Tochon-Danguy H; Scott FE; Kotsuma M; Hirotani K; Senaldi G; Scott AM Theranostics; 2018; 8(15):4199-4209. PubMed ID: 30128047 [TBL] [Abstract][Full Text] [Related]
2. Burvenich IJ; Lee FT; Guo N; Gan HK; Rigopoulos A; Parslow AC; O'Keefe GJ; Gong SJ; Tochon-Danguy H; Rudd SE; Donnelly PS; Kotsuma M; Ohtsuka T; Senaldi G; Scott AM Theranostics; 2016; 6(12):2225-2234. PubMed ID: 27924159 [No Abstract] [Full Text] [Related]
3. Development of DS-5573a: A novel afucosylated mAb directed at B7-H3 with potent antitumor activity. Nagase-Zembutsu A; Hirotani K; Yamato M; Yamaguchi J; Takata T; Yoshida M; Fukuchi K; Yazawa M; Takahashi S; Agatsuma T Cancer Sci; 2016 May; 107(5):674-81. PubMed ID: 26914241 [TBL] [Abstract][Full Text] [Related]
4. Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a. Burvenich IJ; Parakh S; Gan HK; Lee FT; Guo N; Rigopoulos A; Lee ST; Gong S; O'Keefe GJ; Tochon-Danguy H; Kotsuma M; Hasegawa J; Senaldi G; Scott AM J Nucl Med; 2016 Jun; 57(6):974-80. PubMed ID: 26940768 [TBL] [Abstract][Full Text] [Related]
5. Positron-Emission Tomography of HER2-Positive Breast Cancer Xenografts in Mice with Al-Saden N; Lam K; Chan C; Reilly RM Mol Pharm; 2018 Aug; 15(8):3383-3393. PubMed ID: 29957952 [TBL] [Abstract][Full Text] [Related]
8. Preclinical radiolabeling, in vivo biodistribution and positron emission tomography of a novel pyrrolobenzodiazepine (PBD)-based antibody drug conjugate targeting ASCT2. Wichmann CW; Burvenich IJG; Guo N; Rigopoulos A; McDonald A; Cao D; O'Keefe GJ; Gong SJ; Gan HK; Scott FE; Pore N; Coats S; Scott AM Nucl Med Biol; 2023; 122-123():108366. PubMed ID: 37473513 [TBL] [Abstract][Full Text] [Related]
9. Tumor uptake and tumor/blood ratios for [ Al-Saden N; Cai Z; Reilly RM Nucl Med Biol; 2018 Dec; 67():43-51. PubMed ID: 30390575 [TBL] [Abstract][Full Text] [Related]
10. PET imaging of colon cancer CD73 expression using cysteine site-specific Jung KH; Kim M; Jung HJ; Koo HJ; Kim JL; Lee H; Lee KH Sci Rep; 2024 Aug; 14(1):17994. PubMed ID: 39097625 [TBL] [Abstract][Full Text] [Related]
11. Zr-89 Immuno-PET Targeting Ectopic ATP Synthase Enables In-Vivo Imaging of Tumor Angiogenesis. Park BN; Kim GH; Ko SA; Shin GH; Lee SJ; An YS; Yoon JK Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31412537 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer. Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183 [TBL] [Abstract][Full Text] [Related]
13. Probody Therapeutic Design of Giesen D; Broer LN; Lub-de Hooge MN; Popova I; Howng B; Nguyen M; Vasiljeva O; de Vries EGE; Pool M Clin Cancer Res; 2020 Aug; 26(15):3999-4009. PubMed ID: 31953313 [TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Characterization of Allen KJH; Jiao R; Li J; Beckford-Vera DR; Dadachova E Molecules; 2022 Oct; 27(19):. PubMed ID: 36235126 [No Abstract] [Full Text] [Related]
15. Radiolabelling and preclinical characterization of Burvenich IJG; Goh YW; Guo N; Gan HK; Rigopoulos A; Cao D; Liu Z; Ackermann U; Wichmann CW; McDonald AF; Huynh N; O'Keefe GJ; Gong SJ; Scott FE; Li L; Geng W; Zutshi A; Lan Y; Scott AM Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3075-3088. PubMed ID: 33608805 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of (89)Zr-pertuzumab in Breast cancer xenografts. Marquez BV; Ikotun OF; Zheleznyak A; Wright B; Hari-Raj A; Pierce RA; Lapi SE Mol Pharm; 2014 Nov; 11(11):3988-95. PubMed ID: 25058168 [TBL] [Abstract][Full Text] [Related]
17. Antibody-functionalized nanoparticles for imaging cancer: influence of conjugation to gold nanoparticles on the biodistribution of 89Zr-labeled cetuximab in mice. Karmani L; Labar D; Valembois V; Bouchat V; Nagaswaran PG; Bol A; Gillart J; Levêque P; Bouzin C; Bonifazi D; Michiels C; Feron O; Grégoire V; Lucas S; Vander Borght T; Gallez B Contrast Media Mol Imaging; 2013; 8(5):402-8. PubMed ID: 23740810 [TBL] [Abstract][Full Text] [Related]
18. The PET-Tracer Griessinger CM; Olafsen T; Mascioni A; Jiang ZK; Zamilpa C; Jia F; Torgov M; Romero JM; Marchioni F; Satpayev D; Lee C; Zhang G; Nayak TK; Pincha M; Amann M; Mohan PLB; Richard M; Nicolini VG; Sam J; Claus C; Ferrara C; Brünker P; Bacac M; Umana P; Rüttinger D; Wilson IA; Gudas J; Klein C; Tessier JJL Cancer Res; 2020 Jul; 80(13):2903-2913. PubMed ID: 32409308 [TBL] [Abstract][Full Text] [Related]